Dialysis in the older adult: Management of CKD–MBD

Abstract

CKD–MBD is strongly associated with mortality and morbidity in the general dialysis population. The spectrum of clinical long-term consequences of CKD–MBD includes abnormal mineral metabolism; vascular, valvular, and soft-tissue calcifications; uremic bone disease; bone pain; and, last but not least, bone fractures. A consensus statement on treatment targets and principles for CKD–MBD in CKD and dialysis patients has been issued recently in the form of guidelines by the KDIGO group [1]. However, these guidelines do not specifically address specific treatment modalities in the subpopulation of elderly dialysis patients.